Whitehawk Therapeutics Inc
WHWK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $129,185 | $48,215 | $85,595 |
| - Cash | $37,931 | $144,936 | $227,569 | $28,670 |
| + Debt | $0 | $0 | $0 | $833 |
| Enterprise Value | – | -$15,751 | -$179,354 | $57,758 |
| Revenue | $0 | $0 | $7,145 | $7,239 |
| % Growth | – | -100% | -1.3% | – |
| Gross Profit | -$5 | $0 | $6,385 | -$7,898 |
| % Margin | – | – | 89.4% | -109.1% |
| EBITDA | -$17,741 | -$52,599 | -$15,170 | -$18,226 |
| % Margin | – | – | -212.3% | -251.8% |
| Net Income | -$17,746 | -$52,615 | $73,016 | -$18,273 |
| % Margin | – | – | 1,021.9% | -252.4% |
| EPS Diluted | -0.26 | -0.76 | 1.83 | -0.67 |
| % Growth | 65.8% | -141.5% | 373.1% | – |
| Operating Cash Flow | – | -$52,957 | -$11,864 | -$15,053 |
| Capital Expenditures | – | -$1 | -$551 | -$186 |
| Free Cash Flow | – | -$52,958 | -$12,415 | -$15,239 |